Enteral Nutrition Safety and Outcomes of Patients with COVID-19 on Continuous Infusion of Neuromuscular Blockers: A Retrospective Study
Table 1
Baseline characteristics of the study patients.
Nonproned N = 66
Proned N = 115
value
Age (yrs), mean ± SD
62.0 ± 12.8
60.9 ± 14.1
0.62
Male gender, N (%)
51 (78.46%)
77 (66.97%)
0.10
BMI (kg/m2), median (Q1, Q3)
32.8 (28.8, 39.8)
30.2 (25.7, 36.3)
0.01
Comorbidities, N (%)
Diabetes
49 (74.2%)
80 (69.6%)
0.50
Hypertension
44 (66.7%)
74 (64.3%)
0.75
Stroke
4 (6.1%)
6 (5.2%)
1.0
Liver disease
1 (1.5%)
1 (0.9%)
1.0
Asthma
5 (7.6%)
8 (7%)
1.0
Cancer
5 (7.6%)
4 (3.5%)
0.29
Heart failure
7 (10.6%)
8 (7%)
0.39
Chronic kidney disease
10 (15.2%)
11 (9.6%)
0.26
Pertinent laboratory findings on the day of admission to ICU
White blood cells × (109/L), mean ± SD
11.9 ± 6.2
10.0 ± 5.5
0.05
Lymphocyte count × (109/L), mean ± SD
0.8 (0.5, 1.3)
0.9 (0.6, 1.2)
0.93
Neutrophil count × (109/L), mean ± SD
8.8 ± 4.2
7.6 ± 3.8
0.20
Hemoglobin (g/L), median (Q1, Q3)
122 (110, 135)
129 (119, 141)
0.04
Platelet × (109/L), mean ± SD
275.2 ± 130.0
249.5 ± 93.3
0.18
Creatinine (μmol/L), median (Q1, Q3)
105 (73, 162)
93 (72, 138)
0.19
Lactate (mmol/L), median (Q1, Q3)
1.85 (1.35, 2.66)
1.72 (1.15, 2.53)
0.28
Lactate dehydrogenase (U/L), median (Q1, Q3)
604 (476, 809)
643 (508, 824)
0.51
Ferritin (μg/mL), median (Q1, Q3)
824 (463, 2067)
808 (505, 2097)
0.88
Fibrinogen (g/L), mean ± SD
5.6 ± 1.8
5.7 ± 1.6
0.74
D-dimer (μg/mL), median (Q1, Q3)
1.8 (0.8, 4.0)
1.1 (0.7, 3.2)
0.21
C-reactive protein (mg/L), mean ± SD
160.4 ± 82.0
174.0 ± 111.8
0.77
Medications
Corticosteroids, N (%)
48 (72.7%)
91 (79.1%)
0.33
BMI: body mass index, ICU: intensive care unit, Q1: first quartile, Q3: third quartile, and SD: standard deviation. Continuous variables with normal distribution are presented as mean with standard deviation and are compared using the independent t-test (significant at <0.05). Continuous variables with normal distribution are presented as median with the first and third quartile and are compared using Mann–Whitney test (significant at <0.05).
